SlideShare uma empresa Scribd logo
1 de 19
1
Dosage Regimen
Presented By…
Shah Vrushank N.
2
 Introduction
 Multiple Dosing
 Designing of Dosage regimen
 Concept of Loading Dose.
 Maintenance Dose.
 Accumulation Index.
 References
3
Introduction
 Definition :- Dosage regimen is defined as the Manner in
which a drug is taken.
 For successful therapy, design of an optimal multiple dosage
regimen is necessary.
 Multiple dosage regimen:- is defined as the manner in which
the drug is administered in suitable doses by suitable route,
with sufficient frequency that insures maintenance of plasma
conc. within therapeutic window for entire period of therapy.
 In designing a dosage regimen:-
• All p’kinetic parameters of the drug remain constant during the
course of therapy once the Dosage regimen is established.
• The calculations are based on one- compartment model which
can also applied for two- compartment models. β KE
Vd,ss Vd
4
 In Designing dosage
regimen the two major
parameters that can be
adjusted in developing a
dosage regimen are…
1) The Dose size – The qty.
of Drug administered.
 Greater dose size
greater fluctuation btw
Cssmax, & Cssminand greater
chance of toxicity
2) The Dosing frequency –
The time interval
between Doses.
5
Design of dosage regimen from plasma
concentration :
 If the Vd and clearance or half life of the drug is known,
then dosage regimen can be design to maintain the drug
conc. in the therapeutic range.
 Maximum dosing interval which ideally depends upon the
therapeutic index and elimination half life of the drug can
be expressed as :
 ‫ז‬‫ז‬ max = 2.303 log ( Cupper / Clower )
KE
Where KE = 0.693/t1/2
6
 ‫ז‬‫ז‬ max= 3.32 t1/2 log ( Cupper / Clower )
 Mostly dosing interval selected is always smaller than ‫ז‬‫ז‬ max
 the maximum maintenance dose X0maxcan be expressed as
 X0max= Vd ( Cupper - Clower )
F
After the convenient dosing interval ‫ז‬‫ז‬ ,, smaller thansmaller than ‫ז‬‫ז‬ max has
been selected, maintenance dose is given as :
X0 = Css,av =
Xo max
‫ז‬‫ז‬ maxmax
‫ז‬‫ז‬
( Cupper / Clower )
2.303 log ( Cupper / Clower )
7
Multiple dosing
 For chronic diseases, there is necessity of multiple dosing
i.e. administration of drugs in number of frequencies.
 On continuous steady administration of a drug, plasma
concentration will rise fast at first then more slowly and
reach a plateau, where:
Rate of administration = Rate of elimination
( steady state is achieved )
 Therefore, at steady state:
Dose (Rate of Administration) = Clearance x Plasma conc.
Or
If you aim at a target plasma level and you know the
clearance, you can calculate the dose required.`
8
Effect of multiple doses
 If the plasma concentration prior to next dose is >0
concentration and elimination is of first order, then plasma
concentration will increase Increase in elimination rate
and eventually steady state.
– For first order elimination kinetic the time to obtain
steady state is dependent only of the half time of the drug
– The steady state concentration is determinated by dose
(D) and dose frequency
9
 Effects of dose and dose frequencyEffects of dose and dose frequency
 Increase in doseIncrease in dose
– Increase in CIncrease in Cmeanmean
– Larger difference between CLarger difference between Cmaxmax and Cand Cminmin
– Increased risk for side effects for drugs with smallIncreased risk for side effects for drugs with small
therapeutic windowstherapeutic windows
 Increase in frequencyIncrease in frequency
– Increase in CIncrease in Cmeanmean
– Larger inconvenience for patientLarger inconvenience for patient
10
Loading Dose
 Concept of loading dose
 For drugs with long half-lives, the time to reach steady
state might be long. It takes about 5 half- lives to reach
steady state.
 In a such cases the plateau can be achieved by
administering a dose that gives the desired steady- state.
Such an initial/ first dose is called as Loading dose.
XXo,o,L =L =
CCss,avss,av VVdd
FF
11
 When Vd is not known then loading dose may be
calculated as
 The above eq. is applied when Ka >> Ke & drug is
distributed rapidly.
 But in case of I.V. route the absorption is very fast
therefore , absorption phase is neglected then above eq.
XXooLL
XX00 (1 –e(1 –e –Ka–Ka‫ז‬‫ז‬
)) (1 – e(1 – e –Ke–Ke ‫ז‬‫ז‬
)
11
=
XXo,o,LL
XX00
=
1 – e1 – e -Ke-Ke‫ז‬‫ז‬
11
= R= Racac
12
Maintenance Dose
 After the loading dose is given the another dose (I.V) is
given to maintain the steady- state drug conc. Or plateau.
Such dose is known as maintenance dose.
 i.e. maintain the response of drug by replacing drug lost
during dosing interval.
 Maintenance dose = loading dose x ( 1- e -k‫ז‬
)
 Loading dose =
maintenance dosemaintenance dose
1 – e1 – e -K-K ‫ז‬‫ז‬
13
 The ratio of loading dose
to maintenance dose
(X0L/X0) is called as dose
ratio
 When ‫ז‬ = t1/2 the dose ratio
=2.0
 When ‫ז‬ > t1/2 the dose ratio
< 2.0
 when ‫ז‬ < t1/2 the dose ratio
>2.0
14
Accumulation Index
 In case of multiple dosage regimen (drugs are frequently
administered) in such a cases the 1st
drug conc. remaining
in a body after certain time, is added to the next dose, this
condition is known as ‘Accumulation’
 The accumulation occurs because previous doses has not
been removed completely from body.
 After some time the rate of absorption is equal to rate of
elimination i.e. conc. of drug in plasma approaches to a
constant value this condition is called as steady- state,
plateau/ infusion equilibrium.
15
16
 Consider the Amount of drug in the body-time profile as
shown in the Graph.
 After admin of first dose X0 = 1X0
 At next dosing interval when X = ½ X0, amt of drug
remaining in the body
 Admin of next i.v. dose raises the body content to
X = X0+ 1
/2X0
 As the amount of drug in the body rises gradually due to
Accumulation, the rate of elimination also rises
proportionally until a steady-state or Plateau is reached.
17
 The maximum & minimum values of X i.e. Xss,max & Xss,min
approach respective asymptotes at plateau.
 Plateau Xss,min = 1X0 (amt of drug in body after first dose ) Xss,max =
2X0 ( equals twice the first dose)
 Also (Xss,max- Xss,min) = X0
 Xss,max / Xss,min = 2
 All this applied only when ‫ז‬ = t1/2
18
 When ‫ז‬ < t1/2 , the degree of Accumulation is greater & vice-
versa.
 Thus, the extent to which a drug accumulates in the body
during multiple dosing, is a function of dosing interval &
elimination half life & is independent of dose size.
 The extent to which a drug will accumulate with any dosing
interval in the patient can be derived from information
obtained with a single dose and is given by accumulation
index Rac as:
 =Rac
1
1-e -KE ‫ז‬
19
References
 ‘Applied Biopharmaceutics & Pharmacokinetics’
by Leon Shargel & Andrew B. C. Yu, 4th
Edition
 ‘Biopharmaceutics & Pharmacokinetics’
A Treatise, D. M. Brahmankar & Sunil B. Jaiswal
 ‘Clinical Pharmacokinetics, Concepts &
Application’, 3rd
Edition,
by Malcom Rowland & Thomas N. Tozer, Lea & Febiger
 www.google.com

Mais conteúdo relacionado

Mais procurados

Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
Dr. Kunal Chitnis
 
Physiological pharmacokinetic models
Physiological pharmacokinetic modelsPhysiological pharmacokinetic models
Physiological pharmacokinetic models
Sanjay Yadav
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
Sonam Gandhi
 
Bioavailability studies
Bioavailability studiesBioavailability studies
Bioavailability studies
swapna porandla
 

Mais procurados (20)

Drug Therapy Monitoring
Drug Therapy MonitoringDrug Therapy Monitoring
Drug Therapy Monitoring
 
Multiple Dosage regimen
Multiple Dosage regimenMultiple Dosage regimen
Multiple Dosage regimen
 
Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
Bioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence StudiesBioavailability and Bioequivalence Studies
Bioavailability and Bioequivalence Studies
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
 
pH partition theory of drug absorption
pH partition theory of drug absorptionpH partition theory of drug absorption
pH partition theory of drug absorption
 
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
ONE COMPARTMENT OPEN MODEL I.V BOLUS (Contact me: dr.m.bharathkumar@gmail.com)
 
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptxCONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
CONCEPT OF LOADING AND MAINTAINANCE DOSE.pptx
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
DRUG INTERACTIONS (MECHANISMS OF DRUG-DRUG INTERACTIONS)
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
Physiological pharmacokinetic models
Physiological pharmacokinetic modelsPhysiological pharmacokinetic models
Physiological pharmacokinetic models
 
Urinaryexcreation studies
Urinaryexcreation studiesUrinaryexcreation studies
Urinaryexcreation studies
 
Bioavailability studies
Bioavailability studiesBioavailability studies
Bioavailability studies
 
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
ONE COMPARTMENT OPEN MODEL (I.V INFUSION) (Contact me: dr.m.bharathkumar@gmai...
 
pharmacokinetic drug interactions
 pharmacokinetic drug interactions pharmacokinetic drug interactions
pharmacokinetic drug interactions
 
Designing of dosage regimen
Designing of dosage regimenDesigning of dosage regimen
Designing of dosage regimen
 
Introduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimenIntroduction to dosage regimen and Individualization of dosage regimen
Introduction to dosage regimen and Individualization of dosage regimen
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolusPharmacokinetics / Biopharmaceutics - One compartment model IV bolus
Pharmacokinetics / Biopharmaceutics - One compartment model IV bolus
 

Destaque (6)

IV Infusion
IV InfusionIV Infusion
IV Infusion
 
pharmacokinetic of iv infusion
pharmacokinetic of iv infusionpharmacokinetic of iv infusion
pharmacokinetic of iv infusion
 
Area under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN RArea under the curve- Dr ASHWIN R
Area under the curve- Dr ASHWIN R
 
Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...Applications of pharmacokinetics in new drug development,dosage form design &...
Applications of pharmacokinetics in new drug development,dosage form design &...
 
methods of determining drug absorption ppt
methods of determining drug absorption pptmethods of determining drug absorption ppt
methods of determining drug absorption ppt
 
Biopharmaceutics
BiopharmaceuticsBiopharmaceutics
Biopharmaceutics
 

Semelhante a Dosage regimen

Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
khalafpharm
 

Semelhante a Dosage regimen (20)

Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen Multiple Dosage Oral Administration/ Dosage Regimen
Multiple Dosage Oral Administration/ Dosage Regimen
 
Kinetics of multiple dosing
Kinetics of multiple dosingKinetics of multiple dosing
Kinetics of multiple dosing
 
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem APPLICATIONS OF  PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
APPLICATIONS OF PHARMACOKINETICS Piyush lodhi b. pharma 6th sem
 
multiple-dosage-regimen.pdf
multiple-dosage-regimen.pdfmultiple-dosage-regimen.pdf
multiple-dosage-regimen.pdf
 
Biopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimensBiopharmaceutics: Multiple dosage regimens
Biopharmaceutics: Multiple dosage regimens
 
Application of pharmacokinetics
Application of pharmacokineticsApplication of pharmacokinetics
Application of pharmacokinetics
 
Pharmacokinetic
PharmacokineticPharmacokinetic
Pharmacokinetic
 
dosage regimen.pptx
dosage regimen.pptxdosage regimen.pptx
dosage regimen.pptx
 
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciencesTherapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
Therapeutic drug monitoring LECTURE 2.pptx pharmaceutical sciences
 
sustained release oral dosage forms
sustained release oral dosage formssustained release oral dosage forms
sustained release oral dosage forms
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
6-Plasma Half Life and factor affecting.pptx
6-Plasma Half Life and factor affecting.pptx6-Plasma Half Life and factor affecting.pptx
6-Plasma Half Life and factor affecting.pptx
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
One compartment model IV Infusion
One compartment model IV InfusionOne compartment model IV Infusion
One compartment model IV Infusion
 
Determination of dose and dosing interval
Determination of dose and dosing intervalDetermination of dose and dosing interval
Determination of dose and dosing interval
 
01Introduction SRDDS AND CRDDS.pptx
01Introduction SRDDS AND CRDDS.pptx01Introduction SRDDS AND CRDDS.pptx
01Introduction SRDDS AND CRDDS.pptx
 
pharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptxpharmacokinetics .Pharm.D(one compartment).pptx
pharmacokinetics .Pharm.D(one compartment).pptx
 
2.pharmacokinetics
2.pharmacokinetics2.pharmacokinetics
2.pharmacokinetics
 
Dosage Regimen
Dosage RegimenDosage Regimen
Dosage Regimen
 
one compartment open model
one compartment open modelone compartment open model
one compartment open model
 

Último

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 

Último (20)

FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Google Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptxGoogle Gemini An AI Revolution in Education.pptx
Google Gemini An AI Revolution in Education.pptx
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdfUGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
UGC NET Paper 1 Mathematical Reasoning & Aptitude.pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 

Dosage regimen

  • 2. 2  Introduction  Multiple Dosing  Designing of Dosage regimen  Concept of Loading Dose.  Maintenance Dose.  Accumulation Index.  References
  • 3. 3 Introduction  Definition :- Dosage regimen is defined as the Manner in which a drug is taken.  For successful therapy, design of an optimal multiple dosage regimen is necessary.  Multiple dosage regimen:- is defined as the manner in which the drug is administered in suitable doses by suitable route, with sufficient frequency that insures maintenance of plasma conc. within therapeutic window for entire period of therapy.  In designing a dosage regimen:- • All p’kinetic parameters of the drug remain constant during the course of therapy once the Dosage regimen is established. • The calculations are based on one- compartment model which can also applied for two- compartment models. β KE Vd,ss Vd
  • 4. 4  In Designing dosage regimen the two major parameters that can be adjusted in developing a dosage regimen are… 1) The Dose size – The qty. of Drug administered.  Greater dose size greater fluctuation btw Cssmax, & Cssminand greater chance of toxicity 2) The Dosing frequency – The time interval between Doses.
  • 5. 5 Design of dosage regimen from plasma concentration :  If the Vd and clearance or half life of the drug is known, then dosage regimen can be design to maintain the drug conc. in the therapeutic range.  Maximum dosing interval which ideally depends upon the therapeutic index and elimination half life of the drug can be expressed as :  ‫ז‬‫ז‬ max = 2.303 log ( Cupper / Clower ) KE Where KE = 0.693/t1/2
  • 6. 6  ‫ז‬‫ז‬ max= 3.32 t1/2 log ( Cupper / Clower )  Mostly dosing interval selected is always smaller than ‫ז‬‫ז‬ max  the maximum maintenance dose X0maxcan be expressed as  X0max= Vd ( Cupper - Clower ) F After the convenient dosing interval ‫ז‬‫ז‬ ,, smaller thansmaller than ‫ז‬‫ז‬ max has been selected, maintenance dose is given as : X0 = Css,av = Xo max ‫ז‬‫ז‬ maxmax ‫ז‬‫ז‬ ( Cupper / Clower ) 2.303 log ( Cupper / Clower )
  • 7. 7 Multiple dosing  For chronic diseases, there is necessity of multiple dosing i.e. administration of drugs in number of frequencies.  On continuous steady administration of a drug, plasma concentration will rise fast at first then more slowly and reach a plateau, where: Rate of administration = Rate of elimination ( steady state is achieved )  Therefore, at steady state: Dose (Rate of Administration) = Clearance x Plasma conc. Or If you aim at a target plasma level and you know the clearance, you can calculate the dose required.`
  • 8. 8 Effect of multiple doses  If the plasma concentration prior to next dose is >0 concentration and elimination is of first order, then plasma concentration will increase Increase in elimination rate and eventually steady state. – For first order elimination kinetic the time to obtain steady state is dependent only of the half time of the drug – The steady state concentration is determinated by dose (D) and dose frequency
  • 9. 9  Effects of dose and dose frequencyEffects of dose and dose frequency  Increase in doseIncrease in dose – Increase in CIncrease in Cmeanmean – Larger difference between CLarger difference between Cmaxmax and Cand Cminmin – Increased risk for side effects for drugs with smallIncreased risk for side effects for drugs with small therapeutic windowstherapeutic windows  Increase in frequencyIncrease in frequency – Increase in CIncrease in Cmeanmean – Larger inconvenience for patientLarger inconvenience for patient
  • 10. 10 Loading Dose  Concept of loading dose  For drugs with long half-lives, the time to reach steady state might be long. It takes about 5 half- lives to reach steady state.  In a such cases the plateau can be achieved by administering a dose that gives the desired steady- state. Such an initial/ first dose is called as Loading dose. XXo,o,L =L = CCss,avss,av VVdd FF
  • 11. 11  When Vd is not known then loading dose may be calculated as  The above eq. is applied when Ka >> Ke & drug is distributed rapidly.  But in case of I.V. route the absorption is very fast therefore , absorption phase is neglected then above eq. XXooLL XX00 (1 –e(1 –e –Ka–Ka‫ז‬‫ז‬ )) (1 – e(1 – e –Ke–Ke ‫ז‬‫ז‬ ) 11 = XXo,o,LL XX00 = 1 – e1 – e -Ke-Ke‫ז‬‫ז‬ 11 = R= Racac
  • 12. 12 Maintenance Dose  After the loading dose is given the another dose (I.V) is given to maintain the steady- state drug conc. Or plateau. Such dose is known as maintenance dose.  i.e. maintain the response of drug by replacing drug lost during dosing interval.  Maintenance dose = loading dose x ( 1- e -k‫ז‬ )  Loading dose = maintenance dosemaintenance dose 1 – e1 – e -K-K ‫ז‬‫ז‬
  • 13. 13  The ratio of loading dose to maintenance dose (X0L/X0) is called as dose ratio  When ‫ז‬ = t1/2 the dose ratio =2.0  When ‫ז‬ > t1/2 the dose ratio < 2.0  when ‫ז‬ < t1/2 the dose ratio >2.0
  • 14. 14 Accumulation Index  In case of multiple dosage regimen (drugs are frequently administered) in such a cases the 1st drug conc. remaining in a body after certain time, is added to the next dose, this condition is known as ‘Accumulation’  The accumulation occurs because previous doses has not been removed completely from body.  After some time the rate of absorption is equal to rate of elimination i.e. conc. of drug in plasma approaches to a constant value this condition is called as steady- state, plateau/ infusion equilibrium.
  • 15. 15
  • 16. 16  Consider the Amount of drug in the body-time profile as shown in the Graph.  After admin of first dose X0 = 1X0  At next dosing interval when X = ½ X0, amt of drug remaining in the body  Admin of next i.v. dose raises the body content to X = X0+ 1 /2X0  As the amount of drug in the body rises gradually due to Accumulation, the rate of elimination also rises proportionally until a steady-state or Plateau is reached.
  • 17. 17  The maximum & minimum values of X i.e. Xss,max & Xss,min approach respective asymptotes at plateau.  Plateau Xss,min = 1X0 (amt of drug in body after first dose ) Xss,max = 2X0 ( equals twice the first dose)  Also (Xss,max- Xss,min) = X0  Xss,max / Xss,min = 2  All this applied only when ‫ז‬ = t1/2
  • 18. 18  When ‫ז‬ < t1/2 , the degree of Accumulation is greater & vice- versa.  Thus, the extent to which a drug accumulates in the body during multiple dosing, is a function of dosing interval & elimination half life & is independent of dose size.  The extent to which a drug will accumulate with any dosing interval in the patient can be derived from information obtained with a single dose and is given by accumulation index Rac as:  =Rac 1 1-e -KE ‫ז‬
  • 19. 19 References  ‘Applied Biopharmaceutics & Pharmacokinetics’ by Leon Shargel & Andrew B. C. Yu, 4th Edition  ‘Biopharmaceutics & Pharmacokinetics’ A Treatise, D. M. Brahmankar & Sunil B. Jaiswal  ‘Clinical Pharmacokinetics, Concepts & Application’, 3rd Edition, by Malcom Rowland & Thomas N. Tozer, Lea & Febiger  www.google.com